These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26285786)

  • 21. Role of chemokines in the biology of natural killer cells.
    Robertson MJ
    J Leukoc Biol; 2002 Feb; 71(2):173-83. PubMed ID: 11818437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosenescence of human natural killer cells.
    Gayoso I; Sanchez-Correa B; Campos C; Alonso C; Pera A; Casado JG; Morgado S; Tarazona R; Solana R
    J Innate Immun; 2011; 3(4):337-43. PubMed ID: 21576928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human natural killer cell subsets and acute exercise: a brief review.
    Timmons BW; Cieslak T
    Exerc Immunol Rev; 2008; 14():8-23. PubMed ID: 19203081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal stimulation for IVF treatment positively affects the CD56bright/CD56dim NK cell ratio of the endometrium during the window of implantation.
    Lukassen HG; Joosten I; van Cranenbroek B; van Lierop MJ; Bulten J; Braat DD; van der Meer A
    Mol Hum Reprod; 2004 Jul; 10(7):513-20. PubMed ID: 15155817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of opioid therapy on human natural killer cells.
    Tabellini G; Borsani E; Benassi M; Patrizi O; Ricotta D; Caimi L; Lanzi R; Micheli F; Iorno V; Bettaglio R; Rezzani R; Rodella LF; Parolini S
    Int Immunopharmacol; 2014 Jan; 18(1):169-74. PubMed ID: 24287448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
    Riley CH; Hansen M; Brimnes MK; Hasselbalch HC; Bjerrum OW; Straten PT; Svane IM; Jensen MK
    Eur J Haematol; 2015 Mar; 94(3):227-34. PubMed ID: 25082025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells.
    Schwichtenberg SC; Wisgalla A; Schroeder-Castagno M; Alvarez-González C; Schlickeiser S; Siebert N; Bellmann-Strobl J; Wernecke KD; Paul F; Dörr J; Infante-Duarte C
    Neurotherapeutics; 2021 Jul; 18(3):1783-1797. PubMed ID: 34244929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells.
    Vukicevic M; Chalandon Y; Helg C; Matthes T; Dantin C; Huard B; Chizzolini C; Passweg J; Roosnek E
    Eur J Immunol; 2010 Nov; 40(11):3246-54. PubMed ID: 20957748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
    Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
    J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.
    Melsen JE; Lugthart G; Lankester AC; Schilham MW
    Front Immunol; 2016; 7():262. PubMed ID: 27446091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage.
    King K; Smith S; Chapman M; Sacks G
    Hum Reprod; 2010 Jan; 25(1):52-8. PubMed ID: 19819893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel epitope of N-CAM defines precursors of human adherent NK cells.
    Li S; Xu J; Makarenkova VP; Tjandrawan T; Vakkila J; Reichert T; Gooding W; Lagenaur CF; Achim CL; Chambers WH; Herberman RB; Whiteside TL; Vujanovic NL
    J Leukoc Biol; 2004 Dec; 76(6):1187-99. PubMed ID: 15356097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome.
    Thum MY; Bhaskaran S; Bansal AS; Shehata H; Ford B; Sumar N; Abdalla HI
    Hum Reprod; 2005 May; 20(5):1272-6. PubMed ID: 15829490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade.
    Mehling M; Brinkmann V; Burgener AV; Gubser P; Luster AD; Kappos L; Hess C
    J Allergy Clin Immunol; 2013 May; 131(5):1440-3.e7. PubMed ID: 23434284
    [No Abstract]   [Full Text] [Related]  

  • 36. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells.
    Vitale M; Della Chiesa M; Carlomagno S; Romagnani C; Thiel A; Moretta L; Moretta A
    Eur J Immunol; 2004 Jun; 34(6):1715-22. PubMed ID: 15162442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
    Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
    Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells.
    Wendt K; Wilk E; Buyny S; Buer J; Schmidt RE; Jacobs R
    J Leukoc Biol; 2006 Dec; 80(6):1529-41. PubMed ID: 16966385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic virus treatment differentially affects the CD56
    Wantoch M; Wilson EB; Droop AP; Phillips SL; Coffey M; El-Sherbiny YM; Holmes TD; Melcher AA; Wetherill LF; Cook GP
    Immunology; 2022 May; 166(1):104-120. PubMed ID: 35156714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.